Rigel Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]
Rigel Pharmaceuticals, Inc. (RIGL)
Last rigel pharmaceuticals, inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.rigel.com
Company Research
Source: Yahoo! Finance
a record Q4 of $65.4 million (TAVALISSE $45.6M, GAVRETO $10.2M, REZLIDHIA $9.6M) aided by a Medicare Part D affordability tailwind and favorable gross-to-net dynamics. R289 clinical progress: Lead candidate R289 showed early Phase 1b efficacy in lower-risk MDS (33% transfusion independence among evaluable patients at =500 mg), has started a randomized 40-patient dose-expansion, and Rigel expects a Phase 2 dose decision in H2 with topline expansion data by year-end. Financials and strategy: A large non-cash deferred tax benefit drove GAAP net income to $268.1M in Q4 and $367.0M for 2025, Rigel finished the year with $155M in cash and guided 2026 revenue to $275–290M while pursuing late-stage in-licensing to expand the portfolio. Interested in Rigel Pharmaceuticals, Inc.? Here are five stocks we like better. Rigel Pharmaceuticals (NASDAQ:RIGL) detailed record commercial performance for the fourth quarter and full year 2025, while outlining plans to pursue additional in-licensing
Show less
Read more
Impact Snapshot
Event Time:
RIGL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RIGL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RIGL alerts
High impacting Rigel Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
RIGL
News
- How The Rigel Pharmaceuticals (RIGL) Story Is Shifting With New Targets And Pipeline Progress [Yahoo! Finance]Yahoo! Finance
- Rigel Pharmaceuticals Inc (RIGL) Q4 2025 Earnings Call Highlights: Record Net Income and ... [Yahoo! Finance]Yahoo! Finance
- Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates [Yahoo! Finance]Yahoo! Finance
- Rigel Pharma (RIGL) Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
RIGL
Earnings
- 3/3/26 - Beat
RIGL
Analyst Actions
- 1/14/26 - Citigroup Inc.
RIGL
Sec Filings
- 3/3/26 - Form 8-K
- 3/3/26 - Form 10-K
- 2/24/26 - Form 4
- RIGL's page on the SEC website